Literature DB >> 29658821

Top Ten Tips for Palliative Care Clinicians Caring for Cancer Patients Receiving Immunotherapies.

Alison C Wiesenthal1, Sandip P Patel2, Thomas W LeBlanc3, Eric J Roeland4, Arif H Kamal3,5.   

Abstract

Patients with cancer face an ever-changing landscape of tumor-directed therapies available to improve quality of life and potentially increase survival. The most recent advances, immunotherapeutics, offer a novel way to target cancer cells by engaging the body's own immune system. Using an expert panel of oncologists, palliative medicine physicians, and dual-trained specialists, we discuss current immunotherapies and their clinical uses, potential side effects and management strategies, and the implications of these newer treatments on goals of care conversations and care coordination. We aim to further engage palliative care specialists in the active care of cancer patients receiving immunotherapeutics and use a "Top 10" tips format to concisely present practical learning points to busy clinicians.

Entities:  

Keywords:  cancer patients; immunotherapeutics; immunotherapy; palliative care; tumor-directed therapies

Mesh:

Year:  2018        PMID: 29658821     DOI: 10.1089/jpm.2018.0107

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Quality of telephone-based cancer symptom management by nurses: a quality improvement project.

Authors:  Dawn Stacey; Claire Ludwig; Lynne Jolicoeur; Meg Carley; Katelyn Balchin; Lindsay Jibb; Freya Kelly; Craig Kuziemsky; Suzanne Madore; Lisa Rambout; Michael M Vickers; Lorraine Martelli
Journal:  Support Care Cancer       Date:  2020-06-04       Impact factor: 3.603

2.  Research priorities for the pan-Canadian Oncology Symptom Triage and Remote Support practice guides: a modified nominal group consensus.

Authors:  L A Jibb; D Stacey; M Carley; A Davis; I D Graham; E Green; L Jolicoeur; C Kuziemsky; C Ludwig; T Truant
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

3.  Palliative oncology and palliative care.

Authors:  Peter Strang
Journal:  Mol Oncol       Date:  2022-08-12       Impact factor: 7.449

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.